Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
GenFleet Therapeutics
company
About
GenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.
- 11 - 50
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- ¥500M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥500M
GenFleet Therapeutics has raised a total of
¥500M
in funding over 2 rounds. Their latest funding was raised on
Dec 31, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 31, 2021 | Series C | ¥500M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
GenFleet Therapeutics is funded by 3 investors.
Qiaojing Eastern Investment
and Wenzhou Dongchuang Xinhui
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
|
|
— | Series C |
Shanjin Capital
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
